MedTrace Logo

Long Term Cardiovascular Complications in Men With Obstructive Sleep Apnea

NCT01475682 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 167

Last updated 2014-07-17

No results posted yet for this study

Summary

Subjects with Obstructive Sleep Apnea (OSA) are at increased risk of developing cardiometabolic complications, and effective long-term nCPAP treatment significantly reduces the risk of cardiovascular morbidity and mortality.

Conditions

Sponsors & Collaborators

  • The University of Hong Kong

    lead OTHER

Principal Investigators

  • Jamie C Lam, MD · The University of Hong Kong

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2015-05-31
Completion
2015-05-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01475682 on ClinicalTrials.gov